131 related articles for article (PubMed ID: 17634441)
1. Angiotensin inhibition decreases progression of advanced atherosclerosis and stabilizes established atherosclerotic plaques.
Suganuma E; Babaev VR; Motojima M; Zuo Y; Ayabe N; Fogo AB; Ichikawa I; Linton MF; Fazio S; Kon V
J Am Soc Nephrol; 2007 Aug; 18(8):2311-9. PubMed ID: 17634441
[TBL] [Abstract][Full Text] [Related]
2. Antiatherogenic effects of angiotensin receptor antagonism in mild renal dysfunction.
Suganuma E; Zuo Y; Ayabe N; Ma J; Babaev VR; Linton MF; Fazio S; Ichikawa I; Fogo AB; Kon V
J Am Soc Nephrol; 2006 Feb; 17(2):433-41. PubMed ID: 16371432
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the renin-angiotensin system abolishes the proatherogenic effect of uremia in apolipoprotein E-deficient mice.
Bro S; Binder CJ; Witztum JL; Olgaard K; Nielsen LB
Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1080-6. PubMed ID: 17347482
[TBL] [Abstract][Full Text] [Related]
4. The long-term effect of angiotensin II type 1a receptor deficiency on hypercholesterolemia-induced atherosclerosis.
Eto H; Miyata M; Shirasawa T; Akasaki Y; Hamada N; Nagaki A; Orihara K; Biro S; Tei C
Hypertens Res; 2008 Aug; 31(8):1631-42. PubMed ID: 18971539
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of angiotensin II on atherogenesis at the aortic sinus and descending aorta of apolipoprotein-E-deficient mice.
Zhou Y; Chen R; Catanzaro SE; Hu L; Dansky HM; Catanzaro DF
Am J Hypertens; 2005 Apr; 18(4 Pt 1):486-92. PubMed ID: 15831357
[TBL] [Abstract][Full Text] [Related]
6. Monocyte chemoattractant protein-1 is an essential inflammatory mediator in angiotensin II-induced progression of established atherosclerosis in hypercholesterolemic mice.
Ni W; Kitamoto S; Ishibashi M; Usui M; Inoue S; Hiasa K; Zhao Q; Nishida K; Takeshita A; Egashira K
Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):534-9. PubMed ID: 14739122
[TBL] [Abstract][Full Text] [Related]
7. A novel thromboxane receptor antagonist and synthase inhibitor, BM-573, reduces development and progression of atherosclerosis in LDL receptor deficient mice.
Cyrus T; Yao Y; Ding T; Dogné JM; Praticò D
Eur J Pharmacol; 2007 Apr; 561(1-3):105-11. PubMed ID: 17306791
[TBL] [Abstract][Full Text] [Related]
8. Changes in the composition of the thoracic aortic wall in spontaneously hypertensive rats treated with losartan or spironolactone.
Han WQ; Wu LY; Zhou HY; Zhang J; Che ZQ; Wu YJ; Liu JJ; Zhu DL; Gao PJ
Clin Exp Pharmacol Physiol; 2009 May; 36(5-6):583-8. PubMed ID: 19673944
[TBL] [Abstract][Full Text] [Related]
9. Loss of matrix metalloproteinase-9 or matrix metalloproteinase-12 protects apolipoprotein E-deficient mice against atherosclerotic media destruction but differentially affects plaque growth.
Luttun A; Lutgens E; Manderveld A; Maris K; Collen D; Carmeliet P; Moons L
Circulation; 2004 Mar; 109(11):1408-14. PubMed ID: 14993123
[TBL] [Abstract][Full Text] [Related]
10. Essential role of angiotensin II type 1a receptors in the host vascular wall, but not the bone marrow, in the pathogenesis of angiotensin II-induced atherosclerosis.
Koga J; Egashira K; Matoba T; Kubo M; Ihara Y; Iwai M; Horiuchi M; Sunagawa K
Hypertens Res; 2008 Sep; 31(9):1791-800. PubMed ID: 18971558
[TBL] [Abstract][Full Text] [Related]
11. Comparison of angiotensin-(1-7), losartan and their combination on atherosclerotic plaque formation in apolipoprotein E knockout mice.
Yang J; Sun Y; Dong M; Yang X; Meng X; Niu R; Guan J; Zhang Y; Zhang C
Atherosclerosis; 2015 Jun; 240(2):544-9. PubMed ID: 25957120
[TBL] [Abstract][Full Text] [Related]
12. Disruption of the cathepsin K gene reduces atherosclerosis progression and induces plaque fibrosis but accelerates macrophage foam cell formation.
Lutgens E; Lutgens SP; Faber BC; Heeneman S; Gijbels MM; de Winther MP; Frederik P; van der Made I; Daugherty A; Sijbers AM; Fisher A; Long CJ; Saftig P; Black D; Daemen MJ; Cleutjens KB
Circulation; 2006 Jan; 113(1):98-107. PubMed ID: 16365196
[TBL] [Abstract][Full Text] [Related]
13. Renin inhibition reduces atherosclerotic plaque neovessel formation and regresses advanced atherosclerotic plaques.
Wu H; Cheng XW; Hu L; Hao CN; Hayashi M; Takeshita K; Hamrah MS; Shi GP; Kuzuya M; Murohara T
Atherosclerosis; 2014 Dec; 237(2):739-47. PubMed ID: 25463114
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin type 2 receptor is expressed in murine atherosclerotic lesions and modulates lesion evolution.
Sales VL; Sukhova GK; Lopez-Ilasaca MA; Libby P; Dzau VJ; Pratt RE
Circulation; 2005 Nov; 112(21):3328-36. PubMed ID: 16286588
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of the ligand-RAGE pathway via the angiotensin II type I receptor is essential in the pathogenesis of diabetic atherosclerosis.
Ihara Y; Egashira K; Nakano K; Ohtani K; Kubo M; Koga J; Iwai M; Horiuchi M; Gang Z; Yamagishi S; Sunagawa K
J Mol Cell Cardiol; 2007 Oct; 43(4):455-64. PubMed ID: 17761193
[TBL] [Abstract][Full Text] [Related]
16. Blood pressure is the major driving force for plaque formation in aortic-constricted ApoE-/- mice.
Johansson ME; Wickman A; Skøtt O; Gan LM; Bergström G
J Hypertens; 2006 Oct; 24(10):2001-8. PubMed ID: 16957560
[TBL] [Abstract][Full Text] [Related]
17. Genetic deletion or antibody blockade of alpha1beta1 integrin induces a stable plaque phenotype in ApoE-/- mice.
Schapira K; Lutgens E; de Fougerolles A; Sprague A; Roemen A; Gardner H; Koteliansky V; Daemen M; Heeneman S
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1917-24. PubMed ID: 15976328
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin-(1-7) dose-dependently inhibits atherosclerotic lesion formation and enhances plaque stability by targeting vascular cells.
Yang JM; Dong M; Meng X; Zhao YX; Yang XY; Liu XL; Hao PP; Li JJ; Wang XP; Zhang K; Gao F; Zhao XQ; Zhang MX; Zhang Y; Zhang C
Arterioscler Thromb Vasc Biol; 2013 Aug; 33(8):1978-85. PubMed ID: 23723368
[TBL] [Abstract][Full Text] [Related]
19. Long-term administration of 3-deazaadenosine does not alter progression of advanced atherosclerotic lesions in apolipoprotein E-deficient mice.
Preusch MR; Bea F; Yang SH; Kreuzer J; Isermann B; Pedal I; Rosenfeld ME; Katus HA; Blessing E
J Cardiovasc Pharmacol; 2007 Aug; 50(2):206-12. PubMed ID: 17703138
[TBL] [Abstract][Full Text] [Related]
20. Lysosomal cysteine proteases in atherosclerosis.
Liu J; Sukhova GK; Sun JS; Xu WH; Libby P; Shi GP
Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1359-66. PubMed ID: 15178558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
